Saturday Jul 26
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
Amgen today announced findings from the pivotal fracture trial evaluating its RANK Ligand inhibitor, denosumab, in the treatment of postmenopausal osteoporosis.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Amgen's help now problem for some | Aug 9 | LadyIsREAL | 2 |
| Biz Buzz: Business briefs for Thursday, July 31... | Jul 31 | Madeline McCann | 1 |
| Is Amgen Hiring? | Jul 28 | The mex | 2 |
| EU Panel Backs Curbing Use Of Anemia Drugs In C... | Jun '08 | gdpawel | 1 |
| Simi Valley man gets two years for embezzling f... | May '08 | love animals | 1 |
| FDA panel gives surprise OK to Amgen and J&J | Mar '08 | Treat Cancer | 3 |
| Limits proposed for anemia drugs | Mar '08 | Dr Bendover | 4 |

